BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29221732)

  • 21. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
    Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
    Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controversial Issues: When the drugs don't work, can surgery provide a different outcome for diabetic adolescents?
    Beamish AJ; D'Alessio DA; Inge TH
    Surg Obes Relat Dis; 2015; 11(4):946-8. PubMed ID: 25980332
    [No Abstract]   [Full Text] [Related]  

  • 23. Surgical and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Class I Obese Patients: a Short-Term Outcome.
    Bhandari M; Mathur W; Kumar R; Mishra A; Bhandari M
    Obes Surg; 2017 Dec; 27(12):3267-3272. PubMed ID: 28601988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of various gastrointestinal procedures on β-cell function in obesity and type 2 diabetes.
    Malin SK; Kashyap SR
    Surg Obes Relat Dis; 2016 Jul; 12(6):1213-9. PubMed ID: 27568472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Pilot Study of an Acceptance-Based Behavioral Intervention for Weight Regain After Bariatric Surgery.
    Bradley LE; Forman EM; Kerrigan SG; Butryn ML; Herbert JD; Sarwer DB
    Obes Surg; 2016 Oct; 26(10):2433-41. PubMed ID: 26964997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Options for Poor Responders to Bariatric Surgery.
    Lee PC; Dixon JB; Sim PY; Lim CH
    Curr Obes Rep; 2020 Sep; 9(3):364-372. PubMed ID: 32447714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term use of liraglutide in the management of patients with weight regain after bariatric surgery.
    Pajecki D; Halpern A; Cercato C; Mancini M; de Cleva R; Santo MA
    Rev Col Bras Cir; 2013; 40(3):191-5. PubMed ID: 23912365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic gastric banding in a kidney-pancreas transplant recipient with new onset type II diabetes mellitus associated with morbid obesity.
    Bonatti H; Schmitt T; Northup J; Schirmer B; Swenson BR; Pruett TL; Sawyer RG; Brayman K
    Clin Transplant; 2008; 22(6):829-32. PubMed ID: 18713268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Project HELP: a Remotely Delivered Behavioral Intervention for Weight Regain after Bariatric Surgery.
    Bradley LE; Forman EM; Kerrigan SG; Goldstein SP; Butryn ML; Thomas JG; Herbert JD; Sarwer DB
    Obes Surg; 2017 Mar; 27(3):586-598. PubMed ID: 27586525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery.
    Camastra S; Manco M; Mari A; Greco AV; Frascerra S; Mingrone G; Ferrannini E
    Diabetes Care; 2007 Apr; 30(4):1002-4. PubMed ID: 17392562
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.
    Laubner K; Riedel N; Fink K; Holl RW; Welp R; Kempe HP; Lautenbach A; Schlensak M; Stengel R; Eberl T; Dederichs F; Schwacha H; Seufert J; Aberle J
    Diabetes Obes Metab; 2018 Aug; 20(8):1868-1877. PubMed ID: 29569313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reoperative bariatric surgery for treatment of type 2 diabetes mellitus.
    Yan J; Cohen R; Aminian A
    Surg Obes Relat Dis; 2017 Aug; 13(8):1412-1421. PubMed ID: 28647410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidisciplinary treatment of a patient with type 2 diabetes and morbid obesity, or perhaps already a surgical diabetology.
    Szcześniak G; Jaworska J; Jaworski T; Dziemidok P
    Ann Agric Environ Med; 2012; 19(4):798-801. PubMed ID: 23311810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bariatric surgery may reduce the risk of Alzheimer's diseases through GLP-1 mediated neuroprotective effects.
    Keshava HB; Mowla A; Heinberg LJ; Schauer PR; Brethauer SA; Aminian A
    Med Hypotheses; 2017 Jul; 104():4-9. PubMed ID: 28673587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
    Spector D; Shikora S
    Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bariatric surgery or medical therapy for obesity.
    Frontoni S; Malandrucco I; Bonadonna RC
    N Engl J Med; 2012 Aug; 367(5):473-4; author reply 474-6. PubMed ID: 22853020
    [No Abstract]   [Full Text] [Related]  

  • 37. Bariatric surgery or medical therapy for obesity.
    Gletsu-Miller N; Ziegler TR
    N Engl J Med; 2012 Aug; 367(5):473; author reply 474-6. PubMed ID: 22853019
    [No Abstract]   [Full Text] [Related]  

  • 38. Sleeve Gastrectomy and Diabetes: Is Cure Possible?
    Andalib A; Aminian A
    Adv Surg; 2017 Sep; 51(1):29-40. PubMed ID: 28797344
    [No Abstract]   [Full Text] [Related]  

  • 39. Bariatric Surgery as a Long-Term Treatment for Type 2 Diabetes/Metabolic Syndrome.
    Hanipah ZN; Schauer PR
    Annu Rev Med; 2020 Jan; 71():1-15. PubMed ID: 31986081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.